NASDAQ:CMLF

CM Life Sciences Competitors

$13.98
-0.39 (-2.71 %)
(As of 04/14/2021 12:00 AM ET)
Add
Compare
Today's Range
$13.80
Now: $13.98
$14.47
50-Day Range
$13.63
MA: $16.45
$20.98
52-Week Range
$9.66
Now: $13.98
$27.18
Volume450,072 shs
Average Volume1.63 million shs
Market Capitalization$773.71 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

CM Life Sciences (NASDAQ:CMLF) Vs. AJAX, AJAX, BTWN, BOAC, BOWX, and VYGG

Should you be buying CMLF stock or one of its competitors? Companies in the industry of "shell companies" are considered alternatives and competitors to CM Life Sciences, including Ajax I (AJAX), Ajax I (AJAX), Bridgetown (BTWN), Bluescape Opportunities Acquisition (BOAC), BowX Acquisition (BOWX), and Vy Global Growth (VYGG).

Ajax I (NYSE:AJAX) and CM Life Sciences (NASDAQ:CMLF) are both small-cap unclassified companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, profitability, earnings, dividends, valuation, analyst recommendations and institutional ownership.

Profitability

This table compares Ajax I and CM Life Sciences' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Ajax IN/AN/AN/A
CM Life SciencesN/AN/AN/A

Analyst Ratings

This is a breakdown of recent recommendations and price targets for Ajax I and CM Life Sciences, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Ajax I0000N/A
CM Life Sciences0000N/A

Valuation and Earnings

This table compares Ajax I and CM Life Sciences' revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ajax IN/AN/AN/AN/AN/A
CM Life SciencesN/AN/AN/AN/AN/A

Ajax I (NYSE:AJAX) and CM Life Sciences (NASDAQ:CMLF) are both small-cap unclassified companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, profitability, earnings, dividends, valuation, analyst recommendations and institutional ownership.

Profitability

This table compares Ajax I and CM Life Sciences' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Ajax IN/AN/AN/A
CM Life SciencesN/AN/AN/A

Analyst Ratings

This is a breakdown of recent recommendations and price targets for Ajax I and CM Life Sciences, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Ajax I0000N/A
CM Life Sciences0000N/A

Valuation and Earnings

This table compares Ajax I and CM Life Sciences' revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ajax IN/AN/AN/AN/AN/A
CM Life SciencesN/AN/AN/AN/AN/A

Bridgetown (NASDAQ:BTWN) and CM Life Sciences (NASDAQ:CMLF) are both small-cap unclassified companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, profitability, earnings, dividends, valuation, analyst recommendations and institutional ownership.

Profitability

This table compares Bridgetown and CM Life Sciences' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
BridgetownN/AN/AN/A
CM Life SciencesN/AN/AN/A

Analyst Ratings

This is a breakdown of recent recommendations and price targets for Bridgetown and CM Life Sciences, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Bridgetown0000N/A
CM Life Sciences0000N/A

Valuation and Earnings

This table compares Bridgetown and CM Life Sciences' revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BridgetownN/AN/AN/AN/AN/A
CM Life SciencesN/AN/AN/AN/AN/A

Bluescape Opportunities Acquisition (NYSE:BOAC) and CM Life Sciences (NASDAQ:CMLF) are both small-cap unclassified companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, valuation, risk, institutional ownership, profitability and dividends.

Earnings and Valuation

This table compares Bluescape Opportunities Acquisition and CM Life Sciences' revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bluescape Opportunities AcquisitionN/AN/AN/AN/AN/A
CM Life SciencesN/AN/AN/AN/AN/A

Analyst Recommendations

This is a breakdown of recent recommendations for Bluescape Opportunities Acquisition and CM Life Sciences, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Bluescape Opportunities Acquisition0000N/A
CM Life Sciences0000N/A

Profitability

This table compares Bluescape Opportunities Acquisition and CM Life Sciences' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Bluescape Opportunities AcquisitionN/AN/AN/A
CM Life SciencesN/AN/AN/A

CM Life Sciences (NASDAQ:CMLF) and BowX Acquisition (NASDAQ:BOWX) are both small-cap financial services companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, risk, earnings, profitability, institutional ownership, valuation and dividends.

Earnings & Valuation

This table compares CM Life Sciences and BowX Acquisition's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CM Life SciencesN/AN/AN/AN/AN/A
BowX AcquisitionN/AN/AN/AN/AN/A

Analyst Ratings

This is a breakdown of recent ratings for CM Life Sciences and BowX Acquisition, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
CM Life Sciences0000N/A
BowX Acquisition0000N/A

Profitability

This table compares CM Life Sciences and BowX Acquisition's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
CM Life SciencesN/AN/AN/A
BowX AcquisitionN/AN/AN/A

CM Life Sciences (NASDAQ:CMLF) and Vy Global Growth (NYSE:VYGG) are both small-cap financial services companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, risk, earnings, profitability, institutional ownership, valuation and dividends.

Earnings & Valuation

This table compares CM Life Sciences and Vy Global Growth's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CM Life SciencesN/AN/AN/AN/AN/A
Vy Global GrowthN/AN/AN/AN/AN/A

Analyst Ratings

This is a breakdown of recent ratings for CM Life Sciences and Vy Global Growth, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
CM Life Sciences0000N/A
Vy Global Growth0000N/A

Profitability

This table compares CM Life Sciences and Vy Global Growth's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
CM Life SciencesN/AN/AN/A
Vy Global GrowthN/AN/AN/A


CM Life Sciences Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Ajax I logo
AJAX
Ajax I
0.0$10.11-0.3%$904.27 millionN/A0.00Increase in Short Interest
Ajax I logo
AJAX
Ajax I
0.0$10.11-0.3%$904.27 millionN/A0.00Increase in Short Interest
BTWN
Bridgetown
0.0$10.68-1.3%$794.31 millionN/A0.00
BOAC
Bluescape Opportunities Acquisition
0.0$10.11-0.9%$767.73 millionN/A0.00Decrease in Short Interest
BOWX
BowX Acquisition
0.0$12.45-8.8%$751.67 millionN/A0.00Increase in Short Interest
VYGG
Vy Global Growth
0.0$10.38-0.4%$746.06 millionN/A0.00
TPGY
TPG Pace Beneficial Finance
0.3$16.06-5.5%$702.63 millionN/A0.00
HZON
Horizon Acquisition Co. II
0.0$10.22-0.9%$677.53 millionN/A0.00
LCY
Landcadia Holdings III
1.7$10.42-0.2%$670.79 millionN/A0.00
ACIC
Atlas Crest Investment
0.0$10.01-0.5%$625.63 millionN/A0.00
MIT
Mason Industrial Technology
0.0$9.85-0.2%$615.63 millionN/A0.00News Coverage
VSPR
Vesper Healthcare Acquisition
1.7$10.55-0.8%$606.63 millionN/A0.00Analyst Report
Decrease in Short Interest
HAAC
Health Assurance Acquisition
0.0$10.67-1.4%$590.85 millionN/A0.00
VAQC
Vector Acquisition Corp II
0.0$10.00-0.5%$573.50 millionN/A0.00Quiet Period Expiration
KVSC
Khosla Ventures Acquisition Co. III
0.0$10.15-0.0%$571.16 millionN/A0.00
TPG Pace Tech Opportunities logo
PACE
TPG Pace Tech Opportunities
0.0$10.05-0.0%$565.31 millionN/A0.00
CFII
CF Finance Acquisition Corp. II
0.3$8.39-2.5%$533.60 millionN/A0.00Increase in Short Interest
News Coverage
MUDS
Mudrick Capital Acquisition Co. II
0.0$13.24-0.9%$523.39 millionN/A0.00Unusual Options Activity
MAAC
Montes Archimedes Acquisition
0.0$9.92-0.7%$521.51 millionN/A0.00
MOTV
Motive Capital
0.0$9.92-0.6%$513.36 millionN/A0.00
SNRH
Senior Connect Acquisition Corp. I
0.0$9.86-0.7%$510.26 millionN/A0.00
DGNU
ArcLight Clean Transition Corp. II Unit
0.0$10.20-0.4%$510 millionN/A0.00News Coverage
CTAQ
Carney Technology Acquisition Corp. II
0.0$9.90-0.6%$507.01 millionN/A0.00
IIAC
Investindustrial Acquisition
0.0$9.99-0.3%$502.63 millionN/A0.00
SPNV
Supernova Partners Acquisition
0.0$9.99-0.2%$502.63 millionN/A0.00Increase in Short Interest
EPHY
Epiphany Technology Acquisition
0.0$9.83-0.6%$502.43 millionN/A0.00
GMII
Gores Metropoulos II
0.0$10.01-0.3%$500.50 millionN/A0.00
AGCB
Altimeter Growth Corp. 2
0.0$11.03-0.2%$496.35 millionN/A0.00
KVSB
Khosla Ventures Acquisition Co. II
0.0$10.24-0.4%$472.06 millionN/A0.00
NGAC
NextGen Acquisition
0.0$10.00-0.1%$468.75 millionN/A0.00Increase in Short Interest
News Coverage
SPFR
Jaws Spitfire Acquisition
0.0$10.69-0.1%$461.01 millionN/A0.00
HIGA
H.I.G. Acquisition
0.0$9.98-0.2%$456.47 millionN/A0.00Decrease in Short Interest
GHVI
Gores Holdings VI
0.0$12.96-0.5%$447.12 millionN/A0.00News Coverage
LUXA
Lux Health Tech Acquisition
0.0$10.31-0.8%$444.62 millionN/A0.00Decrease in Short Interest
FSRV
FinServ Acquisition
0.0$13.67-1.3%$436.28 millionN/A0.00
CAP
Capitol Investment Corp. V
0.0$9.98-0.6%$430.39 millionN/A0.00
RMGB
RMG Acquisition Co. II
0.0$9.97-0.0%$429.96 millionN/A0.00
GFX
Golden Falcon Acquisition
0.0$9.89-0.6%$426.51 millionN/A0.00
PCPC
Periphas Capital Partnering
0.0$24.68-0.7%$414.69 millionN/A0.00
PIAI
Prime Impact Acquisition I
0.0$9.92-0.2%$401.87 millionN/A0.00Decrease in Short Interest
News Coverage
NSTB
Northern Star Investment Corp. II
0.0$9.98-0.3%$399.20 millionN/A0.00
HOL
Holicity
0.0$10.57-3.1%$396.38 millionN/A0.00Increase in Short Interest
RAAC
Revolution Acceleration Acquisition
0.0$10.20-0.1%$391.00 millionN/A0.00
TSIA
TS Innovation Acquisitions
0.0$10.30-1.4%$386.25 millionN/A0.00Increase in Short Interest
XPOA
DPCM Capital
0.0$9.98-0.3%$385.48 millionN/A0.00Increase in Short Interest
News Coverage
KVSA
Khosla Ventures Acquisition
0.0$10.57-0.2%$379.46 millionN/A0.00Quiet Period Expiration
IGAC
IG Acquisition
0.0$10.00-0.4%$375 millionN/A0.00Decrease in Short Interest
PRSR
Prospector Capital
0.0$9.87-0.2%$370.13 millionN/A0.00
GMBT
Queen's Gambit Growth Capital
0.0$9.85-0.0%$369.38 millionN/A0.00
HCAR
Healthcare Services Acquisition
0.0$9.82-0.5%$353.52 millionN/A0.00
This page was last updated on 4/15/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.